PCM
BIB icon

Prelude Capital Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Prelude Capital Management’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-949
Closed -$66K – 1317
2020
Q3 		$66K Buy
949
+22
+2% +$1.56K ﹤0.01% 1045
2020
Q2 		$67K Buy
927
+306
+49% +$19.5K ﹤0.01% 1071
2020
Q1 		$29K Buy
+621
New +$34.6K ﹤0.01% 889
2016
Q3 		– Sell
-1,055
Closed -$41K – 1592
2016
Q2 		$41K Sell
1,055
-3,407
-76% -$147K 0.01% 1076
2016
Q1 		$182K Sell
4,462
-3,757
-46% -$166K 0.03% 586
2015
Q4 		$588K Buy
8,219
+1,719
+26% +$115K 0.09% 243
2015
Q3 		$379K Sell
6,500
-29,068
-82% -$2.48M 0.06% 348
2015
Q2 		$3.21M Hold
35,568
– – 0.45% 34
2015
Q1 		$2.82M Hold
35,568
– – 0.39% 47
2014
Q4 		$2.23M Buy
35,568
+640
+2% +$37.6K 0.33% 45
2014
Q3 		$1.82M Buy
34,928
+1,528
+5% +$74K 0.26% 73
2014
Q2 		$1.55M Buy
+33,400
New +$1.32M 0.21% 98
2014
Q1 		– Sell
-30,248
Closed -$1.14M – 1860
2013
Q4 		$1.14M Buy
30,248
+16,000
+112% +$535K 0.19% 121
2013
Q3 		$464K Buy
+14,248
New +$413K 0.07% 315

Other funds holding BIB

SFS
Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Prelude Capital Management's BIB Position: Q4 2020 in Review

Prelude Capital Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2020, closing a stake of 949 shares — an estimated $66K sold.

Prelude Capital Management first reported a position in BIB in Q3 2013 and held it in 14 quarters. The position peaked at $3.21M in Q2 2015. 34 funds tracked by Wall St. Rank hold BIB as of Q4 2020.

  • Prelude Capital Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 949 ProShares Ultra NASDAQ Biotechnology shares in Q4 2020, an estimated $66K.
  • Prelude Capital Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2013 and held it in 14 quarters.
  • Prelude Capital Management's ProShares Ultra NASDAQ Biotechnology position peaked at $3.21M in Q2 2015.
  • 34 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.